These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 4405675)

  • 1. [Use of indocyanine green in the assessment of liver function in schizophrenics].
    Badurski J; Makosa M; Sarosiek J; Tolwiński T
    Pol Tyg Lek; 1973 Jan; 28(4):118-20. PubMed ID: 4405675
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of neuroleptics on the frontal functions of schizophrenics].
    Verdoux H; Magnin E; Bourgeois M
    Ann Med Psychol (Paris); 1994 Oct; 152(8):530-4. PubMed ID: 7818228
    [No Abstract]   [Full Text] [Related]  

  • 3. The relationship of the brief psychiatric rating scale to neuropsychological deficits in phenothiazine-treated schizophrenics.
    Golden CJ; Carpenter B; Wilkening G; Ruedrich S; Chu CC; Graber B
    Psychopharmacol Bull; 1983; 19(3):513-7. PubMed ID: 6138799
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between antipsychotic-induced elevation of liver enzymes and weight gain: a prospective study.
    Rettenbacher MA; Baumgartner S; Eder-Ischia U; Edlinger M; Graziadei I; Hofer A; Huber R; Hummer M; Kemmler G; Weiss E; Fleischhacker WW
    J Clin Psychopharmacol; 2006 Oct; 26(5):500-3. PubMed ID: 16974192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma indocyanine green (ICG) clearance as a liver function test in chronic alcoholism].
    Caban M; Mika M
    Pol Tyg Lek; 1974 Dec; 29(51):2215-6. PubMed ID: 4445038
    [No Abstract]   [Full Text] [Related]  

  • 6. [Usefulness of indocyanine green test in the evaluation of hepatocellular damage in patients with burns].
    Roszkowski S; Zietkiewicz W; Kania B
    Pol Tyg Lek; 1972 Jul; 27(24):903-5. PubMed ID: 5040536
    [No Abstract]   [Full Text] [Related]  

  • 7. [Liver enzyme activity in patients with schizophrenia in the course of treatment with majeptil].
    Danilenko ET; Vlokh II
    Vrach Delo; 1976 Aug; (8):111-4. PubMed ID: 14445
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental and clinical studies of the indocyanine green test].
    Otsuji S; Hamasaki Y; Hayashi Y
    Igaku Kenkyu; 1974 May; 44(2):117-37. PubMed ID: 4476154
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatoparenchymal clearance of indocyanine green in infectious hepatitis].
    Proto C; Grasso G; Fassio PG
    G Mal Infett Parassit; 1968 Sep; 20(9):845-51. PubMed ID: 5710696
    [No Abstract]   [Full Text] [Related]  

  • 10. Preliminary experience in the treatment of schizophrenia with pipothiazine and its derivatives.
    Faltus F; Marecek P; Soucek K
    Act Nerv Super (Praha); 1975 Sep; 17(3):204. PubMed ID: 883
    [No Abstract]   [Full Text] [Related]  

  • 11. [Course studies on cerebral glutamine excretion in schizophrenics under treatment with tranquilizing agents].
    Kluge H; Hartmann W; Wieczorek V; Greger J
    Psychiatr Clin (Basel); 1973; 6(5):288-99. PubMed ID: 4149148
    [No Abstract]   [Full Text] [Related]  

  • 12. Indocyanine green liver function studies on women taking progestins.
    Takaki NK; Mathews CW; Semmens JP
    Obstet Gynecol; 1967 Aug; 30(2):220-7. PubMed ID: 5212328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of decompression of biliary tract on the course of elimination curve of indocyanine green from the blood].
    Krajka K; Kopacz A
    Przegl Lek; 1973; 30(5):437-41. PubMed ID: 4723331
    [No Abstract]   [Full Text] [Related]  

  • 14. Simultaneous measurement of effective hepatic blood flow and systemic circulation.
    Hashimoto M; Watanabe G
    Hepatogastroenterology; 2000; 47(36):1669-74. PubMed ID: 11149029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of chronic hospitalized schizophrenics: diagnosis and treatment.
    Ban TA; Guy W; Wilson WH
    Psychiatr J Univ Ott; 1984 Dec; 9(4):191-5. PubMed ID: 6151202
    [No Abstract]   [Full Text] [Related]  

  • 16. [An attempt to discontinue long-term psychopharmacologic therapy in chronic schizophrenics].
    Klik J; Fait V; Bat'ková Z
    Cesk Psychiatr; 1984 Apr; 80(2):121-4. PubMed ID: 6147204
    [No Abstract]   [Full Text] [Related]  

  • 17. [Absorption of vofaverdin by the liver in circulatory insufficiency, chronic hepatitis and liver cirrhosis].
    Fomichev VI
    Klin Med (Mosk); 1973 Oct; 51(10):94-6. PubMed ID: 4787288
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed peak latency of the mismatch negativity in schizophrenics and alcoholics.
    Kathmann N; Wagner M; Rendtorff N; Engel RR
    Biol Psychiatry; 1995 May; 37(10):754-7. PubMed ID: 7640331
    [No Abstract]   [Full Text] [Related]  

  • 19. Kraepelinian schizophrenia: a subgroup of schizophrenia?
    Keefe RS; Mohs RC; Davidson M; Losonczy MF; Silverman JM; Lesser JC; Horvath TB; Davis KL
    Psychopharmacol Bull; 1988; 24(1):56-61. PubMed ID: 2898796
    [No Abstract]   [Full Text] [Related]  

  • 20. The long-term treatment of schizophrenia in the community.
    Rollin HR
    Practitioner; 1982 Jul; 226(1369):1330-3. PubMed ID: 6125936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.